Skip to content
OpenCapital
Get started

Progyny PGNY Free cash flow yield

Free cash flow yield at other companies

CVS Health logo
CVS HealthCVS
8.1%—
UnitedHealth Group logo
UnitedHealth GroupUNH
8%+2.8pp
Natera, Inc. logo
Natera, Inc.NTRA
0.4%-0.1pp
Organon logo
OrganonOGN
43.8%+23.6pp
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
3%+1.2pp
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
13.4%-2.3pp

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Calculated from Progyny’s reported figures.

free cash flow/market cap=13.3%

Based on trailing twelve months.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's free cash flow yield?
Progyny (PGNY) reported free cash flow yield of 13.3% in Q1 2026.
How has Progyny's free cash flow yield changed year-over-year?
Progyny's free cash flow yield increased by 29.2% year-over-year, from 10.3% to 13.3%.
What is the long-term trend for Progyny's free cash flow yield?
Over 5 years (2020 to 2025), Progyny's free cash flow yield has grown at a 56.7% compound annual growth rate (CAGR), from 0.9% to 8.7%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.